Fifty percent of all U.S. healthcare payments now run through value-based care contracts. That number has been climbing for three years straight. And yet, two-thirds of health systems report that their quality metrics haven't meaningfully improved since they signed those contracts.
That gap doesn't happen by accident.
It happens because most organizations treat value-based care software as a procurement exercise rather than an infrastructure decision. They buy a platform. They run a pilot. They wait for the dashboards to tell them something useful. And then — 18 months into a contract with real financial consequences — they realize the data isn't actionable, the workflows aren't connected, and the AI they were promised is basically a fancier spreadsheet.
This is the state of value-based care software in the USA right now. A fast-growing market, genuinely transformative technology, and far too many organizations running the wrong implementation playbook.
Here's what's actually separating the organizations that are winning from the ones quietly bleeding shared savings.
The Infrastructure Problem Nobody Talks About
The value-based care payment market hit $3.17 billion in 2025 and is on track to reach $5.02 billion by 2030 at a 9.5% CAGR. That growth tells you one thing clearly: the financial pressure to perform under outcome-based contracts is accelerating, not plateauing.
But here's what those market projections don't tell you: buying a value-based care platform and building value-based infrastructure are two completely different things.
Infrastructure means your clinical data, payer claims, pharmacy records, lab results, and social determinants of health all flow into one place — in real time, not overnight. Only 29% of U.S. hospitals can currently integrate data from outside providers into their EHRs. That's not a technology gap. That's an architecture decision that most procurement teams don't ask about until it's too late.
A purpose-built care management platform like AssureCare's MedCompass doesn't just aggregate data — it structures it into the 360-degree patient view that care teams need to intervene before an avoidable admission happens. That's a fundamentally different design than bolting analytics onto a legacy EHR.
The organizations winning under VBC contracts right now didn't just select better software. They rebuilt the data flow underneath it. That's the infrastructure problem. And it's fixable — but only if you know to look for it.
📌 The stat that should stop you cold:
40% of physicians say value-based care creates more workload — not because the model is broken, but because most VBC software still forces manual data reconciliation. Fix the workflow, and the resistance drops. Fix the infrastructure, and the workflow fixes itself.
Where AI-Powered Healthcare Analytics Actually Change the Math
Let's be precise about what AI does in a value-based care context — because the hype has gotten so loud that it's obscuring the actual mechanics.
Predictive analytics in VBC software does three things that rule-based software cannot:
- It identifies patients before they become expensive. AI-based monitoring tools have produced an 18% reduction in hospital readmissions in documented studies. That's not marginal improvement. For a 500-bed system, 18% fewer readmissions can mean seven-figure savings annually.
- It automates the administrative drag that kills care team capacity. Organizations deploying AI across clinical and administrative workflows report 20–30% efficiency gains and a 63% reduction in claims review times. Those aren't pilot numbers — they're production outcomes.
- It surfaces patterns that claims data can't see. Social determinants of health — housing instability, food insecurity, transportation barriers — account for 30–55% of health outcomes but don't show up in a claims feed. AI-powered healthcare analytics solutions that integrate SDoH can flag these risk signals before they become emergency department visits.
$3.20
ROI for every $1 spent on healthcare AIHospitals deploying AI analytics typically reach this return within 14 months of implementation. More than half of U.S. health systems that can now quantify AI ROI report a 2× return.
The question isn't whether AI works in healthcare. It's whether your current platform is actually running it — or just labeling a basic algorithm as "AI-powered."
AssureCare's healthcare analytics for payors through Akumen is built on this principle: every insight needs to be actionable at the care team level, not just visible on an executive dashboard. That's the difference between analytics as a reporting tool and analytics as a care delivery mechanism.
Seventy-five percent of U.S. health systems are now using at least one AI application — up from 59% just one year ago. But using AI and operationalizing AI are different thresholds. The organizations crossing the second threshold are the ones with contracts that pay.
The Three Stakeholders Who Get This Wrong Most Often
Value-based care software isn't a single-buyer decision. The platform that works for a commercial health plan is architecturally different from what an ACO needs — and both are different from what a pharmacy network requires to participate in outcome-based contracts. Getting this wrong is expensive.
PayorsOver-invest in stratification tools. Under-invest in the intervention layer. Stratification without outreach is just a risk list.
Providers / ACOsUnderestimate how quickly quality measure performance becomes a daily operational concern, not a quarterly report.
PharmaciesMost underutilized stakeholder in VBC. Medication non-adherence costs $300B+ annually — pharmacists are untapped care gap closers.
Payors
The shift that's producing results in 2026 is closed-loop engagement: identify the high-risk member, trigger a personalized outreach campaign, track the response, and update the risk model based on what happened. That loop — from identification to intervention to data capture — has to run without manual intervention at every step.
AssureCare's patient engagement tools through Aktivate™ are purpose-built for exactly that loop — enterprise-grade activation that replaces fragmented outreach with continuous, personalized, compliant engagement at scale.
Providers — ACOs, IPAs, and Risk-Bearing Entities
Provider organizations entering shared savings arrangements frequently underestimate how quickly quality measure performance becomes a daily operational concern rather than a quarterly report. HEDIS and STAR gaps don't close at the end of the year — they close one patient interaction at a time, every day. Platforms that surface those gaps at the point of care, in the workflow, in real time are the ones producing measurable shared savings.
The CMS TEAM Model, now mandatory for more than 748 hospitals entering 2026, requires episode-based accountability across care transitions. That's not achievable with a platform that reports outcomes retroactively. You need prospective intelligence.
Pharmacies
Retail, community, and specialty pharmacies are the most underutilized stakeholder in value-based care. Medication non-adherence alone accounts for approximately $300 billion in avoidable healthcare costs annually in the United States. Pharmacists who identify adherence risk, flag adverse event patterns, and close care gaps don't just improve patient outcomes — they become billable participants in payer contracts. AssureCare's pharmacy value-based programs through AssureRx are built to operationalize exactly that shift.
What to Actually Evaluate When Selecting Healthcare Software Solutions
Most vendor evaluations focus on feature checklists. That's the wrong lens. Under value-based contracts, the criteria that matter are speed, integration depth, and workflow fidelity — not the number of modules on the pricing page.
Four questions that should anchor every VBC software evaluation:
- How long does data integration actually take in a live deployment? Not the demo environment. The median go-live timeline for enterprise healthcare software solutions requiring custom integration is 9–14 months. The best platforms are live in 6–8 weeks because they're built around pre-certified data connectors, not custom middleware.
- Does the AI surface actionable next steps or just risk scores? A risk score that a care manager has to manually interpret is a reporting tool. An AI that flags a specific patient, suggests a specific intervention, and logs the outcome is a care delivery tool. That distinction is worth 10× in operational impact.
- Can the platform serve multiple stakeholders without separate implementations? The organizational overhead of managing disconnected payer, provider, and pharmacy tools is itself a source of care fragmentation. One partner, one data model, purpose-built for each role — that's the architecture that scales.
- Is the AI responsible, auditable, and HIPAA-compliant by default? 33% of healthcare AI leaders cite data privacy and sovereignty as their single biggest adoption challenge. Any platform where you have to ask about data governance is already a red flag.
These aren't aspirational criteria. They're operational requirements for any organization running under VBC contracts in 2026.
The Organizations That Wait Are Already Behind
Over 60% of health organizations expect higher VBC revenue in 2026. Capitated models have doubled since 2021. The CMS TEAM Model is live. This isn't a future challenge — it's a present operational reality.
The gap between organizations capturing shared savings and those posting quality penalties isn't a gap in intent. It's a gap in infrastructure. The right AI-powered healthcare analytics solutions don't just report on performance — they drive it, in real time, across every stakeholder in the care continuum.
That's what purpose-built value-based care software looks like when it's actually working.
See the Platform Built for Outcomes, Not Just Reports
AssureCare builds population health management solutions for payors, providers, and pharmacies who are serious about thriving under value-based contracts — not just surviving them.
MedCompass · Aktivate™ · Akumen · AssureRx · OptimAIzer
Explore Our SolutionsConnect With the Team
Frequently Asked Questions
What is value-based care software, and why does it matter for U.S. healthcare organizations?
Value-based care software connects clinical data, claims, pharmacy records, and social determinants of health to help payors, providers, and pharmacies manage patient populations under outcome-based contracts. In the U.S., more than 50% of healthcare payments now run through VBC models — organizations without the right platform face both quality penalties and missed shared savings opportunities.
How do AI-powered healthcare analytics solutions reduce costs in value-based care?
AI-powered analytics identify high-risk patients before they require expensive interventions, automate administrative workflows that drain care team capacity, and surface social determinant signals that claims data misses entirely. Documented outcomes include an 18% reduction in hospital readmissions and 20–30% efficiency gains across clinical and administrative operations. The ROI typically materializes within 14 months of deployment.
What should healthcare organizations look for in value-based care software in the USA?
The non-negotiable criteria are: data integration speed (weeks, not months), real-time AI-driven intervention — not just risk scoring — multi-stakeholder capability across payors, providers, and pharmacies, and HIPAA-compliant AI governance built in by default. Feature checklists matter far less than the platform's ability to close care gaps inside existing clinical workflows without manual reconciliation.
How is AI changing healthcare software solutions for payors and providers in 2026?
In 2026, 75% of U.S. health systems now use at least one AI application — up from 59% just a year ago. For payors, AI enables closed-loop member engagement that replaces fragmented outreach at scale. For providers, it delivers prospective quality gap alerts at the point of care. AI is also compressing prior authorization timelines from days to minutes and reducing claims review time by 63%.
Disclaimer: This content is for informational purposes only and does not constitute medical or clinical advice. Statistics cited reflect third-party research as of 2025–2026.
